Clinical Trial Update: Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating mocravimod as adjunctive and maintenance therapy for adults with acute myeloid leukemia undergoing allogeneic stem cell transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Mocravimod (Mocravimod)

Snippet

Sponsor: Priothera SAS | Conditions: Adult Acute Myeloid Leukemia | Phase 3 | Status: RECRUITING